Dodecanoate

Dodecanoate

SCHEMBL230531

CCCCCCCCCCCC(=O)[O-].CCCC[P+](CCCC)(CCCC)CCCC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 6/20 0.60
NFKB1 P19838 1/20 0.58
CA1 P00915 1/20 0.58
GPR84 Q9NQS5 1/20 0.56
DNM1 Q05193 2/20 0.56
CA2 P00918 2/20 0.55
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL9063410 1.00 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Octanoic Acid SCHEMBL16008346 1.00 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Myristic Acid SCHEMBL15091865 1.00 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Decanoic Acid SCHEMBL3323693 1.00 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Palmitic Acid SCHEMBL15091868 1.00 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Octanoic Acid SCHEMBL16007959 0.98 DNM1 (0.60) FABP3NFKB1CA1GPR84DNM1
SCHEMBL253165 0.98 CA1 (0.60) FABP3NFKB1CA1GPR84DNM1
Hexanoate SCHEMBL28546350 0.98 CA1 (0.60) FABP3NFKB1CA1GPR84DNM1
Octanoic Acid SCHEMBL11573973 0.96 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1
Decanoic Acid SCHEMBL194214 0.96 FABP3 (0.60) FABP3NFKB1CA1GPR84DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250142194-A1 BONDED BODY, MANUFACTURING METHOD OF BONDED BODY, IMAGING MODULE, ELECTRONIC DEVICE, AND RESIN COMPOSITION CANON KABUSHIKI KAISHA (JP) 2025-05-01 US claimed
US-20260109860-A1 HEAT-CURABLE RESIN COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-23 US disclosed
EP-4729563-A1 HEAT-CURABLE RESIN COMPOSITION SHIN-ETSU CHEMICAL CO., LTD., (JP) 2026-04-22 EP disclosed
US-12565608-B2 Thermally conductive resin composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-03-03 US disclosed
EP-4679461-A2 RESIN COMPOSITION AND PRODUCTION METHOD OF THE SAME AJINOMOTO CO., INC. (JP) 2026-01-14 EP disclosed
US-20250346788-A1 POLYMALEIMIDE RESIN, RESIN COMPOSITION, CURED OBJECT, SHEET, LAMINATE, AND PRINTED WIRING BOARD RESONAC CORP (JP) 2025-11-13 US disclosed
US-20250324789-A1 IMAGING MODULE AND IMAGING APPARATUS CANON KK (JP) 2025-10-16 US disclosed
US-20250277087-A1 MALEIMIDE RESIN, RESIN COMPOSITION, CURED PRODUCT, SHEET, LAMINATE, AND PRINTED WIRING BOARD RESONAC CORPORATION (JP) 2025-09-04 US disclosed
EP-4586285-A1 RESIN COMPOSITION AJINOMOTO CO., INC. (JP) 2025-07-16 EP disclosed
CN-120192630-A Resin composition 味之素株式会社 2025-06-24 CN disclosed
EP-2647667-A1 CURABLE EPOXY RESIN COMPOSITION Daicel Corporation (JP) 2013-10-09 EP disclosed
US-20130241086-A1 CURABLE EPOXY RESIN COMPOSITION DAICEL CORPORATION (JP) 2013-09-19 US disclosed
US-20130178559-A1 FIBER-REINFORCED RESIN COMPOSITE MATERIAL DAICEL CORPORATION (JP) 2013-07-11 US disclosed
US-8399575-B2 Crosslinkable materials based on organosilicon compounds WACKER CHEMIE AG (DE) 2013-03-19 US disclosed
US-20120004364-A1 Crosslinkable Materials Based On Organosilicon Compounds WACKER CHEMIE AG (DE) 2012-01-05 US disclosed
EP-2031024-B1 Crosslinkable materials based on organosilicon compounds WACKER CHEMIE AG (DE) 2010-02-24 EP disclosed
EP-2150577-A1 CROSS-LINKABLE MASSES COMPRISING PHOSPHORUS COMPOUNDS Wacker Chemie AG (DE) 2010-02-10 EP disclosed
US-20090062471-A1 CROSSLINKABLE MATERIALS BASED ON ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2009-03-05 US disclosed
EP-2031024-A1 Crosslinkable materials based on organosilicon compounds Wacker Chemie AG (DE) 2009-03-04 EP disclosed
WO-2008141951-A1 CROSS-LINKABLE MASSES COMPRISING PHOSPHORUS COMPOUNDS WACKER CHEMIE AG (DE) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565608-B2 Thermally conductive resin composition ITGAM, RAE1, FCGR1A FABP3 3999/4885NFKB1 2614/4885CA1 1109/4885
US-20260109860-A1 HEAT-CURABLE RESIN COMPOSITION RAD51, COL2A1, SEM1 FABP3 4826/4885NFKB1 2562/4885CA1 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.